多巴胺对人纹状体的成像及其调控Imaging the Human Striatum and its Modulation by Dopamine |
|
课程网址: | http://videolectures.net/mitworld_cools_ihsmd/ |
主讲教师: | Roshan Cools |
开课单位: | 奈梅根拉德堡大学 |
开课时间: | 2010-08-09 |
课程语种: | 英语 |
中文简介: | Roshan Cools告诉我们,研究人员已经知道神经递质多巴胺在一段时间内集中参与学习和工作记忆,并且多巴胺响应电路将人脑的这些部分连接到其他结构,如纹状体,这也有助于协调运动控制。 Cools一直在研究多巴胺如何在这些皮质纹状体回路中起作用以影响不同类型的认知加工。具体而言,Cools研究了多巴胺能药物(调节神经元可利用的多巴胺量或神经元对多巴胺的反应性的化合物)的作用。 )对人类主体进行各种表演任务。她指出,这类药物存在“个体内部和个体之间的巨大差异”。同一受试者中的相同化学物质可以改善一项任务的表现,并在另一项任务中损害它。药物效应取决于个体多巴胺的基线水平:如果某人开始时水平不理想,多巴胺增强药物可以使某人恢复到基线水平,而以多巴胺水平最佳开始的人可能会被同一种药物过量服用。冷却研究之一研究了多巴胺能药物对帕金森病(PD)患者的影响,其中“主要病理是纹状体中多巴胺耗竭。”这种消耗在疾病的早期和晚期并不均匀,并影响不同部位在纹状体中。早期PD患者的运动缺陷多于高水平的皮质缺陷。通过性能测试和fMRI扫描,Cools证实了她的假设,即在轻度PD中,多巴胺增强药物会影响概率性逆转学习(更高水平的认知任务)的表现,“可能是通过在纹状体的一部分中过量使用相对完整的多巴胺水平”。然而,这些相同的药物改善了与与运动系统有关的部分纹状体相关的其他任务的性能.Cools最近一直在测试健康的U.C. Berkeley本科生使用多巴胺能药物,fMRI和PET扫描,了解多巴胺的水平如何影响他们在不同学习任务中的表现。冷却说,“多巴胺能药物可以改善奖励但会损害低多巴胺受试者和PD患者的基于惩罚的学习。相反,它改善了惩罚,但在高多巴胺受试者中损害了基于奖励的逆转学习。基于奖赏和惩罚的逆转之间的平衡的这种转变可能反映了多巴胺对纹状体加工的调节。“ |
课程简介: | Researchers have known for some time that the neurotransmitter dopamine is centrally involved in learning and working memory, Roshan Cools tells us, and that dopamine-responsive circuits connect these parts of the human brain to other structures like the striatum, which also helps orchestrate motor control. Cools has been investigating in detail how dopamine acts within these cortico-striatal circuits to influence different types of cognitive processing. Specifically, Cools examined the effects of dopaminergic drugs (compounds that modulate the quantity of dopamine available to neurons, or the neurons’ responsiveness to dopamine) on human subjects as they performed a variety of performance tasks. She notes that there’s a “huge variability within and across individuals” to such drugs. The same chemical within the same subject may improve performance in one task, and impair it in another. The drug effect depends on an individual’s baseline levels of dopamine: If someone starts with suboptimal levels, a dopamine-enhancing drug can restore someone to baseline, whereas someone starting with optimal levels of dopamine might be overdosed by the same drug. One of Cools’ studies looked at the impact of dopaminergic drugs in Parkinson’s disease (PD) patients, where “the primary pathology is dopamine depletion in the striatum.” This depletion is not uniform, though, in the early and late stages of the disease, and impacts different sites in the striatum. Early stage PD patients suffer more from motor deficiencies than from higher level cortical deficiencies. Through performance tests and fMRI scans,Cools confirmed her hypothesis that in mild PD, dopamine-enhancing medication impaired performance on probabilistic reversal learning (a higher level cognitive task), “presumably by overdosing relatively intact levels of dopamine” in one part of the striatum. Yet these same drugs improved performance on other tasks associated with a part of the striatum concerned with motor systems. Cools has recently been testing healthy U.C. Berkeley undergrads with dopaminergic drugs, fMRI and PET scans, to see how levels of dopamine impact their performance on different learning tasks. Says Cools, “Dopaminergic medication improves reward- but impairs punishment-based learning in low-dopamine subjects and PD patients. Conversely, it improves punishment- but impairs reward-based reversal learning in high-dopamine subjects. This shift in the balance between reward- and punishment-based reversal likely reflects modulation by dopamine of striatal processing.” |
关 键 词: | 多巴胺; 响应电路; 神经元 |
课程来源: | 视频讲座网 |
最后编审: | 2019-05-21:cwx |
阅读次数: | 117 |